After meta-analysis of these studies, we found that up-regulation of PVT1 was significantly associated with poor OS in patients with ccRCC (HR = 1.51, 95% CI = 1.02–2.00, Fig. 4). This evidence concerns the gene PVT1 and nonpapillary renal cell carcinoma.